IMPACT OF CORONARY ARTERY DISEASE ON CLINICAL OUTCOMES AFTER TAVR: INSIGHTS FROM THE BRAVO-3 RANDOMIZED TRIALDaniel Feldman, George Dangas, Christian Hengstenberg et al.|Journal of the American College of Cardiology|2022Cited by 2